Leaderboard

En | De
No articles selected!     View Cart  
You are here: Respiratory Tract » Neoplasms 27. May 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7996  Previews Next
   
   Articles 1 - 20 / 159914  
   
Integrative analysis and experimental validation of dioxin-interacting genes reveal diagnostic and prognostic biomarkers in lung adenocarcinoma.
Clin Exp Med
Yin G, Li B, Fan S, Wang Z, Jiang Q, He F, Cao H, Liang Y, Luo Y, Jiang F, Fan X.
PMID: 42189270 [PubMed - as supplied by publisher]


Geospatial heterogeneity of hotspots for incidence and late-stage diagnosis of breast, colorectal, and lung cancer.
Cancer Causes Control
Loehrer AP, Carlos HA, Weiss JE, Wang Q, Leversedge CV, Katter JE, Phillips JD, Ferrari-Light D, Onega T, Shi X.
PMID: 42189260 [PubMed - in process]


Computed Tomography Versus Pathologic Tumor Size in Resected Lung Tumors: High Correlation, Limited Agreement, and the Impact of Ground-Glass Opacity.
Tomography
Yavuz O, Ertan R, Kertmen M, Iscan M.
PMID: 42188708 [PubMed - in process]


Efficient Estimation Methods for the QR Distribution with Type-II Censored Data: An Empirical Validation on Lung Cancer Prognosis.
Entropy (Basel)
Ramzan Q, Amin M, Alghamdi S, Alharbi R.
PMID: 42187917 [PubMed - in process]


Applications of Artificial Intelligence in Endobronchial Ultrasound for Lung Cancer Diagnosis and Staging: A Scoping Review.
Curr Oncol
Echeverri-Hoyos J, Echeverri-Franco JA, Bonilla N, Monsalve-Morales G, Tuta-Quintero E.
PMID: 42187604 [PubMed - in process]


Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review.
Curr Oncol
Gherzi L, Alifano M.
PMID: 42187562 [PubMed - in process]


STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.
Curr Oncol
Kulkarni AA, Rock A, Lee M, Reyes A, Patel MR, Kratzke RA, Salgia R.
PMID: 42187558 [PubMed - in process]


Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.
Curr Oncol
Aseyev O, Zrielykh L, Shi M, Filipovic K, Seymour C, Siddiqui R, Biman B.
PMID: 42187557 [PubMed - in process]


Prognostic model of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma: Construction and validation using WGCNA.
Adv Clin Exp Med
Li H, Zhao Z, Li J, Rong Y, Zheng A, Hao M.
PMID: 42186940 [PubMed - as supplied by publisher]


Effects of CALM-based psycho-oncological counseling on the emotional well-being of relatives of people living with lung cancer: Results of a randomized controlled trial.
J Psychosoc Oncol
Dusel J, Meng K, Faßler P, Reinhardt F, Dankert A, Gnecco A, Söll T, Jentschke E.
PMID: 42186802 [PubMed - as supplied by publisher]


A visual analysis of the research dynamics of biomarkers for lung cancer screening.
Clin Epigenetics
Zhu H, Li B, Kong R, Yang J, Guo Z, Yin J.
PMID: 42185923 [PubMed - indexed for MEDLINE]


The landscape of MET alterations in non-small cell lung cancer in Southeastern China: a real-world study.
BMC Cancer
Zheng S, Zuo Z, Lin R, Zhang X, Huang L, Cai M, Ye Y, Yao D, Huang X.
PMID: 42185795 [PubMed - as supplied by publisher]


Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
J Neurooncol
Glynn SE, D'Agostino R Jr, Lanier CM, R Choi A, Farris M, Abdulhaleem M, Young P, Wang Y, Smith M, Ruiz J, Lycan T, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Su J, T Whitlow C, Xing F, Chan MD, Helis CA.
PMID: 42185640 [PubMed - indexed for MEDLINE]


Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study.
Sci Rep
Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L.
PMID: 42185427 [PubMed - as supplied by publisher]


Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis.
Nat Commun
Zhang B, Zhong R, Shi C, Chu T, Zhang W, Wang H, Gan X, Zhang Z, Zhu C, Li X, Su W, Li J, Zhang Y, Han B, Zhong H.
PMID: 42185290 [PubMed - as supplied by publisher]


Mapping the home-based symptom management journey of lung cancer patients receiving combination therapy: A longitudinal qualitative study.
Eur J Oncol Nurs
Chen Q, Zhang C, Zeng Z, Ye B, Lin Q, Arbing R, Chen WT, Huang F.
PMID: 42184547 [PubMed - as supplied by publisher]


A review of deep learning-based multimodal data integration of lung cancer.
Clin Exp Med
Qin Y, Wang S, Wu D, Fei Y, Ding W, Wang Q, Guan R, Liang X.
PMID: 42184020 [PubMed - as supplied by publisher]


A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous Transformation.
Head Neck Pathol
Sibira RM, Chen C, Costa FA, Verma A, Singh P, Peterson JE, Hattery T, Racila E, Zhong M, Murugan P, Dermawan JK.
PMID: 42183964 [PubMed - indexed for MEDLINE]


Neural Correlates of Palliative Care: A Feasibility Trial in Patients with Metastatic Gastrointestinal and Lung Cancer.
Res Sq
Fanouraki E, Knotts JD, Page CA, Perry A, Wager TD, Wheatley TP, Ahern C, Barnato AE.
PMID: 42183384 [PubMed]


Encounter tool for Shared Decision Making about Adjuvant Treatment of Lung Cancer: Randomized Clinical Trial.
Res Sq
Bandi SSS, Branda ME, Chavez MM, Bagewadi S, Norman AS, Montori V, Gionfriddo MR, Hargraves IG, Boehmer K, Stephen A, Sagen C, Montori VM, Brito JP, Leventakos K.
PMID: 42183367 [PubMed]


   
   Articles 1 - 20 / 159914    Page 1 of 7996  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1